variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
WNT10A-F228I,WNT10A,"Causes ectodermal dysplasia in a recessive manner (malformations of teeth and nails, abnormal/loss of sweating). Although reports have high statistical significance, allele frequency for this variant is high relative to the incidence of the disease. This suggests it may be milder than other pathogenic variants and cause disease with less than 100% penetrance and/or that the disease is more common than reported. Bohring et al. report heterozygotes for pathogenic variants in this gene often have milder skin, tooth, and nail abnormalities, with males having a higher rate of tooth abnormalities.",Moderate,Well-established,Pathogenic,0.019,"Mouth, liver, and digestive;Skin",Unknown,Heterozygous,19559398;20979233,,5,chr2,219755011,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
UGT1A1-G71R,UGT1A1,"This variant, also known as UGT1A1*6, is associated with Gilbert syndrome (found in ~5% of the population) and transient hyperbilirubinemia in infants in east asian populations. This allele appears to have incomplete penetrance and causes reduced enzyme activity.",Moderate,Likely,Pathogenic,0.00074,"Mouth, liver, and digestive",Complex/Other,Heterozygous,9929972;18004206,rs4148323,3,chr2,234669144,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
FCGR2B-I232T,FCGR2B,"A study in an Asian population associates this variant with increased susceptibility to anti-glomerular basement membrane antibody disease (anti-GBM), an autoimmune disease that causes bleeding, lung, and kidney disease. Even for carriers of this variation, anti-GBM is quite rare -- this variant only increases absolute risk for the disease by 0.1-0.2%. A much weaker finding seems to correlate homozygosity for the variant with increased risk for systemic lupus erythematosus (SLE); if true, the amount of increased risk due to the variant is unclear.",Low,Likely,Pathogenic,0.13,Breathing;Genital and urinary;Immune system,Complex/Other,Heterozygous,12115230;19640933,rs1050501,0,chr1,161643798,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
PIGR-A580V,PIGR,"In a Japanese study, this variant was associated with an increased risk for immunoglobulin A nephropathy (IgAN), a rare disease. The chances of having this disease, even with this variant, is less than 0.1%.",Low,Likely,Pathogenic,0.25,Genital and urinary;Immune system,Complex/Other,Heterozygous,12740691,rs291102,0,chr1,207106478,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TPMT-Y240C,TPMT,"Alone, this variant is known as TPMT*3C -- but often, especially in Caucasians, it is found together with another nonsynonymous variant (A154T) to produce the TPMT*3A variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity, although *3C is milder than *3A. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Well-established,Pharmacogenetic,0.046,Drug response;Metabolism,Complex/Other,Heterozygous,15228163;15298741;20154640;20354201,rs1142345,2,chr6,18130918,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
ITPA-P32T,ITPA,"This variant is associated with inosine triphosphate pyrophosphohydrolase deficiency and may be associated with an adverse reaction to thiopurine drugs (which are used as immunosuppressants). Homozygotes have no detectable ITPase activity, individuals compound heterozygous with another less severe mutation also have severely reduced enzyme activity.",Low,Well-established,Pharmacogenetic,0.061,Drug response;Immune system;Metabolism,Recessive,Heterozygous,12384777;15322947;17924837;19631656;19682085;20173735,rs1127354,1,chr20,3193842,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Homozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TOR1A-D216H,TOR1A,This SNP has been shown to be benign and play a protective role against Dystonia.  ,Low,Likely,Protective,0.1,Nervous system,Unknown,Heterozygous,18519876;19380705;20669276,rs1801968,1,chr9,132580901,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
LIG4-A3V,LIG4,One report has associated this with a decreased risk of multiple myeloma.,Low,Uncertain,Protective,0.036,Cancer,Dominant,Heterozygous,12471202,rs1805389,1,chr13,108863609,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
FANCI-P55L,FANCI,Probably benign.,Low,Likely,Benign,0.051,Other,Unknown,Heterozygous,17412408,rs62020347,,chr15,89803950,T,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
NLRP3-V200M,NLRP3,"Reported to cause familial cold urticaria by Hoffman et al, in a dominant manner. However the variant is quite common (1 in 50 Europeans is a carrier) while the disease is extremely rare (<1 in 1 million) -- therefore the variant can't be causing this effect.",Low,Likely,Benign,,Other,Unknown,Heterozygous,11687797,rs121908147,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
CBLC-H405Y,CBLC,Probably benign.,Low,Uncertain,Benign,0.037,Other,Unknown,Heterozygous,19370762,rs3208856,,chr19,45296806,T,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
PCCA-I475V,PCCA,"Reported as a polymorphism, tentatively presumed benign.",Low,Uncertain,Benign,0.038,Other,Unknown,Heterozygous,10101253,rs35719359,,chr13,100962156,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
MAPT-Q230R,MAPT,Common polymorphism.,Low,Uncertain,Benign,0.042,Other,Unknown,Heterozygous,15365985,rs63750072,,chr17,44060859,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
EDAR-V370A,EDAR,"Associated with thicker hair, common in Chinese and Japanese individuals and thought to be Asian-specific.",Low,Uncertain,Benign,0.011,Other,Unknown,Heterozygous,18065779;18561327;18704500;19804850,rs3827760,,chr2,109513601,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
BRCA1-Q356R,BRCA1,"One common variant associated this variant with an increased risk of breast cancer, but a more recent, larger study found no association.",Low,Uncertain,Benign,0.046,Cancer,Unknown,Heterozygous,17341484;19661094,rs1799950,,chr17,41246481,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
FANCA-S1088F,FANCA,"Probably benign. One report hypothesized this variant causing Fanconi Anemia, but the allele frequency (3-7%) is high enough to contradict a highly penetrant pathogenic effect. Later authors have concluded this is a polymorphism, not pathogenic.",Low,Uncertain,Benign,0.058,Blood,Unknown,Heterozygous,10094191;14695169,rs17233497,0,chr16,89815152,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
PALB2-E672Q,PALB2,Probably benign.,Low,Uncertain,Benign,0.024,Other,Unknown,Heterozygous,17200668,rs45532440,,chr16,23641461,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
ABCC11-G180R,ABCC11,This variant is associated with dry type ear wax (a benign trait) in a recessive manner.,Low,Uncertain,Benign,0.098,Other,Unknown,Heterozygous,14471313;16444273,rs17822931,,chr16,48258198,T,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
MUSK-T100M,MUSK,Probably benign.,Low,Uncertain,Benign,0.023,Other,Unknown,Heterozygous,,rs35142681,,chr9,113449489,T,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
FLG-R3530S,FLG,"Tentatively classified as benign, although predicted by Polyphen 2 to be damaging. Other more severe null mutations (frameshift and nonsense) in this gene are reported to cause ichthyosis vulgaris in a recessive manner.",Low,Uncertain,Benign,0.11,Skin,Unknown,Heterozygous,,rs72697000,,chr1,152276772,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.pgp-hms.org/genomes?display_genome_id=e3d782c74d30d49af9585d7e3db4fbd85f12d237
